ARCH Venture Management as of June 30, 2022
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 10 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 44.9 | $369M | 2.9M | 126.51 | |
| Eqrx | 20.8 | $170M | 36M | 4.69 | |
| Denali Therapeutics (DNLI) | 18.5 | $152M | 5.2M | 29.43 | |
| Erasca (ERAS) | 7.5 | $62M | 11M | 5.57 | |
| Verve Therapeutics (VERV) | 4.7 | $38M | 2.5M | 15.28 | |
| Singular Genomics Systems In | 1.8 | $15M | 3.8M | 3.82 | |
| Revolution Healthcar Aq Corp | 1.6 | $13M | 1.4M | 9.77 | |
| Metacrine Ord | 0.2 | $1.5M | 2.9M | 0.50 | |
| Rubius Therapeutics | 0.0 | $298k | 350k | 0.85 | |
| Zymergen | 0.0 | $147k | 119k | 1.23 |
